Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Peterson; Jerry A.
Address:
Lafayette, CA
No. of patents:
14
Patents:












Patent Number Title Of Patent Date Issued
6315997 Use of modified antibodies with human milk fat globule specificity November 13, 2001
An analogue peptide that comprises the variable regions of the light or heavy chains of an antibody of a first species selectively binding to a carcinoma antigen has 1 to 46 amino acids of the framework regions per chain substituted with amino acids such as those present in equivalent
6190885 Fusion protein containing HMFG Epitop E (S) February 20, 2001
A fusion protein comprises a sequence of amino acids which binds antibodies specific to the human milk fat globule (HMFG) differentiation antigens. Specific amino acid sequences are provided, and a fusion protein may be used as an immunogen and for diagnostic purposes.
5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein October 26, 1999
A polypeptide has the antibody binding activity of the 46 Kdalton HMFG antigen and/or homology to at least one of the light chains of clotting factors V and VIII and/or contains RGD and/or EGF-like segments. The polypeptide is provided as a recombinant and/or glycosylated and/or fusion
5804187 Modified antibodies with human milk fat globule specificity September 8, 1998
An analogue peptide that comprises the variable regions of the light or heavy chains of an antibody of a first species selectively binding to a carcinoma antigen has 1 to 46 amino acids of the framework regions per chain substituted with amino acids such as those present in equivalent
5792852 Polynucleotides encoding modified antibodies with human milk fat globule specificity August 11, 1998
A polynucleotide encodes a modified antibody, or single chains thereof. The modified antibody has a non-antigen-binding peptide such as the constant regions of an antibody of a first species, peptide hormones, enzymes, and peptide transmitters; and a binding peptide such as the unsubstit
5766571 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturate June 16, 1998
An improved in vivo method of inhibiting or retarding the growth of malignant tumor cells in a subject comprises administering the subject antitumor therapy, the improvement comprising administering to the subject at least one product comprising an agent selected from the group consi
5667797 Anti-viral composition and kit and use for treating rotavirus infection and diarrhea September 16, 1997
An anti-diarrheic product comprises a foodstuff and an anti-rotaviral agent such as human defatted fat globule membranes, the human milk macromolecular fraction, skim milk, curd, whey, the milk mucin complex, the 46 Kd app.MW glycoprotein, a polypeptide having an amino acid sequence
5536647 Nucleic acids and vector encoding HMFQ polypeptide, transfected host, fusion proteins thereof, c July 16, 1996
A polypeptide has the antibody binding activity of the 70K dalton HMFG differentiation antigen and is also provided as a fusion protein with a second antigenic polypeptide. An antibody has affinity for the polypeptide of the invention or a functional fragment thereof. in vivo and in vitr
5532135 Solid-phase competitive assay utilizing a fusion protein July 2, 1996
An in vitro solid-phase, competitive assay for detecting the presence of a peptide analyte in a biological sample comprises contacting a fusion protein, of first and second peptides, with a solid supported first antibody or fragment thereof, which binds the first peptide, adding a bi
5514558 Highly sensitive and specific solid-phase competitive assay utilizing a fusion protein May 7, 1996
An in vitro solid-phase, competitive assay for detecting the presence of a peptide analyte in a biological sample, comprising contacting a fusion protein made of a first peptide and a second peptide to a solid supported first antibody which specifically binds to the first peptide, adding
5505955 Anti-diarrheic product and method of treating rotavirus-associated infection April 9, 1996
An anti-diarrheic product comprises a foodstuff and an anti-rotaviral agent such as human defatted fat globule membranes, the human milk macromolecular fraction, the milk mucin complex, the 46 Kd apparent MW glycoprotein, a polypeptide having the rotavirus-binding specificity of the
5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit a October 3, 1995
A polypeptide has the antibody binding activity of the 46K dalton HMFG differentiation antigen and/or homology to at least one of the light chains of clotting factors V and VIII and is also provided as a fusion protein with a second antigenic polypeptide. An antibody has affinity for
5077220 Monoclonal antibody specific to a novel glycoprotein antigen on human carcinoma cells December 31, 1991
A hybridoma cell line is provided which is capable of producing monoclonal antibodies which bind to a unique determinant site on the surface and/or in the cytoplasm of human breast carcinoma cells and carcinoma cells of other adenocarcinomas and on the surface of normal human breast epit
5075219 Monoclonal antibody which recognizes a specific glycoprotein of a human milk-fat globule membran December 24, 1991
A hybridoma cell line is provided which is capable of producing a monoclonal antibody which binds to a unique determinant site on the surface and in the cytoplasm of human breast carcinoma cells and cells of other adenocarcinomas and does not bind selectively to the surface of normal










 
 
  Recently Added Patents
Method and device for evaluating evolution of tumoural lesions
Semiconductor memory device
Cascode circuit device with improved reverse recovery characteristic
Glove
Error correct coding device, error correct coding method, and error correct coding program
Methods and apparatus for determining a phase error in signals
Load balancing in shortest-path-bridging networks
  Randomly Featured Patents
Programmable logic controller method, system and apparatus
High sensitivity demodulator for a radio tag and method
Hybrid power generation and energy storage system
Reflective type liquid crystal display with reversely staggered TFT structures
Remote control tower device and system
High power semiconductor device having source electrodes connected by air bridges and having opposite current path directions
Antifuse structure having an integrated heating element
Method of non-disruptive capacity scaling for a data storage library
Process for the preparation of resin-bound cyclic peptides
Ergometer